India Plans Incentives for Diabetes and Obesity Drug Manufacturers in 2026, Confirms Government Official
![Government takes significant strides in medical education.](https://healthwire.co/wp-content/uploads/2023/07/medicines.jpg)
India is planning to give incentives to companies that will produce GLP-1 drugs locally in 2026. These drugs are used to treat diabetes and obesity. A top government official shared…
Share